Diadexus (DDXS) Stock Price, News & Analysis

Company Overview

Diadexus, Inc. was a molecular diagnostics company focused on developing, manufacturing and commercializing blood-based tests for cardiovascular disease. Its products were designed to help healthcare providers assess biological factors associated with atherosclerosis and the risk of cardiovascular events.

The company’s principal product was the PLAC Test, which measured lipoprotein-associated phospholipase A2 (Lp-PLA2), an enzyme linked to vascular inflammation. The test was marketed as an aid in assessing cardiovascular risk and was available for clinical use in the United States and other markets.

Diadexus was headquartered in South San Francisco, California, and served the clinical diagnostics market through relationships with healthcare providers, laboratories and other medical organizations. Publicly available information about the company’s later operations, leadership and current business status is limited.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 30 shs
• Average Volume: 15,481 shs
• Market Capitalization: $53 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 10/26/2015
• Today: 11/03/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:DDXS
• CIK: 1036968
• Web: www.diadexus.com
• Phone: (650) 246-6400
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 4,100,000
• Free Float: N/A
• Market Cap: $53 thousand
• Optionable: Not Optionable
• Beta: N/A